51吃瓜网

Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY

v3.23.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
Total
Common Stock
Additional Paid-In Capital
Treasury Stock
Accumulated Deficit
Beginning balance (in shares) at Apr. 30, 2021 25,066,297
Beginning balance at Apr. 30, 2021 $ 49,090,474 $ 25,067 $ 109,040,824 $ (1,817,414) $ (58,158,003)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation 1,965,567 1,965,567
Common stock issued for vested restricted stock units (in shares) 73,708
Common stock issued for vested restricted stock units 0 $ 74 (74)
Common stock issued for stock options exercised for cash (in shares) 58,419
Common stock issued for stock options exercised for cash 191,034 $ 58 190,976
Common stock issued for cashless stock options exercised (in shares) 30,156
Common stock issued for cashless stock options exercised 0 $ 30 (30)
Amortization of warrant based cost 43,708 43,708
Warrants issued for deferred financing costs related to Credit Facility 137,500 137,500
Net loss (7,457,143) (7,457,143)
Ending balance (in shares) at Jan. 31, 2022 25,228,580
Ending balance at Jan. 31, 2022 43,971,140 $ 25,229 111,378,471 (1,817,414) (65,615,146)
Beginning balance (in shares) at Oct. 31, 2021 25,148,194
Beginning balance at Oct. 31, 2021 46,853,315 $ 25,149 110,526,729 (1,817,414) (61,881,149)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation 700,697 700,697
Common stock issued for vested restricted stock units (in shares) 38,719
Common stock issued for vested restricted stock units 0 $ 39 (39)
Common stock issued for stock options exercised for cash (in shares) 41,667
Common stock issued for stock options exercised for cash 135,000 $ 41 134,959
Amortization of warrant based cost 16,125 16,125
Net loss (3,733,997) (3,733,997)
Ending balance (in shares) at Jan. 31, 2022 25,228,580
Ending balance at Jan. 31, 2022 $ 43,971,140 $ 25,229 111,378,471 (1,817,414) (65,615,146)
Beginning balance (in shares) at Apr. 30, 2022 25,202,278 25,357,764
Beginning balance at Apr. 30, 2022 $ 42,545,724 $ 25,358 112,081,564 (1,817,414) (67,743,784)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation 899,176 899,176
Common stock issued for vested restricted stock units (in shares) 192,233
Common stock issued for vested restricted stock units 0 $ 192 (192)
Common stock issued for services (in shares) 25,000
Common stock issued for services 24,500 $ 25 24,475
Common stock issued for equity raise, net of underwriter costs (in shares) 11,840
Common stock issued for equity raise, net of underwriter costs 9,535 $ 12 9,523
Warrants issued for deferred financing costs related to Credit Facility 21,000 21,000
Net loss $ (7,563,651) (7,563,651)
Ending balance (in shares) at Jan. 31, 2023 25,431,351 25,586,837
Ending balance at Jan. 31, 2023 $ 35,936,284 $ 25,587 113,035,546 (1,817,414) (75,307,435)
Beginning balance (in shares) at Oct. 31, 2022 25,460,849
Beginning balance at Oct. 31, 2022 37,089,814 $ 25,461 112,634,162 (1,817,414) (73,752,395)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation 394,510 394,510
Common stock issued for vested restricted stock units (in shares) 125,988
Common stock issued for vested restricted stock units 0 $ 126 (126)
Amortization of warrant based cost 7,000 7,000
Net loss $ (1,555,040) (1,555,040)
Ending balance (in shares) at Jan. 31, 2023 25,431,351 25,586,837
Ending balance at Jan. 31, 2023 $ 35,936,284 $ 25,587 $ 113,035,546 $ (1,817,414) $ (75,307,435)